Loading organizations...
The National Human Genome Research Institute (NHGRI) serves as the primary federal entity driving advancements in genomics research. It focuses on transforming the understanding of human health and disease by conducting and supporting cutting-edge investigations, developing novel genomic technologies, and exploring the ethical, legal, and social implications arising from genomic discoveries. Its comprehensive approach spans foundational research to the application of genomic insights in medicine.
NHGRI originated as the National Center for Human Genome Research (NCHGR), established in 1989 to spearhead the National Institutes of Health’s participation in the monumental International Human Genome Project. This collaborative effort with the U.S. Department of Energy, initiated in 1990, aimed to map the entire human genome. The institute was later officially elevated to its current status and renamed in 1997, building upon the foundational insight that sequencing the human genetic blueprint would unlock unprecedented biomedical opportunities.
The institute’s work benefits the global scientific and medical communities, fostering collaborative research and enabling a deeper understanding of genetics for various conditions. NHGRI's long-term vision is to enhance the health of all individuals through genomic advances, empowering and expanding the field to continually chart new frontiers in biomedical science and clinical application.
National Human Genome Research Institute has 2 tracked investments across 2 companies. The latest tracked deal is $830K Grant in Stratos Genomics in August 2011.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 25, 2011 | Stratos Genomics | $830K Grant | National Human Genome Research Institute | — |
| Oct 15, 2009 | Bionano Genomics | $830K Grant | National Human Genome Research Institute | — |